A carregar...

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies

BACKGROUND: Since most glioblastomas express both wild-type EGFR and EGFRvIII as well as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific antibodies (BiAbs) that target EGFR and HER2. METHODS: ATC were generated from PBMC activated for 14 days with anti-CD3 mono...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zitron, Ian M, Thakur, Archana, Norkina, Oxana, Barger, Geoffrey R, Lum, Lawrence G, Mittal, Sandeep
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599512/
https://ncbi.nlm.nih.gov/pubmed/23433400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-83
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!